Vasc Q Laminate Med

Listing a study does not mean it has been evaluated by the u s.

Vasc q laminate med.

Preliminary data are presented of its use assessing its safety and efficacy for brachiocephalic avfs in haemodialysis patients. Laminate has developed vasq a blood vessel support device for. Laminate medical technologies said today it launched a pivotal fda cleared trial of its vasq implanted blood vessel device designed for patients requiring arteriovenous fistulas as vascular. Laminate medical technologies was founded in 2012 by tammy gilon and dr.

Value vascular access laminate european experience. The israel based company s vasq device is designed to aid kidney failure patients in need of dialysis by providing external support to reduce fistula failure. Vasq is the only solution currently available2that addresses both hemodynamic and mechanical stress to create more usable fistulas promote outward dilative remodeling the nitinol external support controls the remodeling at the anastomosis to promote outward wall thickening downstream for eventual use in hemodialysis. 23 2019 prnewswire the israeli start up laminate medical technologies developer of the vasq external vascular support device for arteriovenous fistulas in patients.

Eyal orion who began their work in the rad biomed incubator. On january 19th laminate medical technologies announced that it launched a pivotal fda cleared trial of its vasq implanted blood vessel device designed for patients requiring arteriovenous fistulas as vascular access for hemodialysis.